The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies Article

cited authors

  • Whitworth, Jenny M.; Matthews, Kellie S.; Shipman, Kimberly A.; Numnum, T. Michael; Kendrick, James E.; Kilgore, Larry C.; Straughn, J. Michael, Jr.

authors

Publication Date

  • March 1, 2009

webpage

published in

category

keywords

  • Granulocyte-colony stimulating factor
  • Gynecologic malignancy
  • Pegfilgrastim
  • Safety

start page

  • 601

end page

  • 604

volume

  • 112

issue

  • 3